Unknown PHASE4 INTERVENTIONAL 2-arm NCT05877131

Evaluate Efficacy Levobupivacaine 0.125% Versuss Ropivacaine 0.2% in Hemodynamic Alterations in Labor and Fetal Repercussions

Randomized Clinical Trial to Evaluate the Efficacy of Levobupivacaine 0.125% vs Ropivacaine 0.2%, in Hemodynamic Alterations in Pregnant Women in Labor and Their Fetal Repercussions

Sponsor: Althaia Xarxa Assistencial Universitària de Manresa

Conditions Epidural Fetal Cardiac Disorder Hemodynamic Instability Pregnancy

Interventions Levobupivacaine Ropivacaine

Updated 4 times since 2023 Last updated: May 17, 2023 Started: Jun 1, 2023 Primary completion: Dec 1, 2023 Completion: Dec 1, 2023

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT05877131, this PHASE4 trial focuses on Epidural and Fetal Cardiac Disorder and remains ongoing. Sponsored by Althaia Xarxa Assistencial Universitària de Manresa, it has been updated 4 times since 2023, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.

Status Flow

Change History

4 versions recorded

Jun 2025 — Present [monthly]

Unknown PHASE4

Status: Not Yet Recruiting → Unknown
Sep 2024 — Jun 2025 [monthly]

Not Yet Recruiting PHASE4
Jul 2024 — Sep 2024 [monthly]

Not Yet Recruiting PHASE4
Jun 2023 — Jul 2024 [monthly]

Not Yet Recruiting PHASE4

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Althaia Xarxa Assistencial Universitària de Manresa

Data source: Althaia Xarxa Assistencial Universitària de Manresa

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Manresa, Spain